Search This Blog

Friday 27 November 2015

News on next EACPT Congress in Prague: 23rd - 27th June, 2017

The next EACPT Congress will be held in Prague from 23rd – 27th June, 2017.
The Prague EACPT Congress in 2017 will provide an international scientific and educational
Prague: Charles bridge and Vltava river
forum for discussion of clinical pharmacology and personalised pharmacotherapy. Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, innovative techniques, and advanced practices in topics such as drug discovery, drug development, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines. 
The Congress will bring together a wide range of international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs. The Congress will include a dedicated session for Young Pharmacologists. 
The following major EACPT Awards will be presented at the Congress.
The EACPT Lifetime Achievement Award is for outstanding contributions to the national and international benefits of clinical pharmacology for medicine, health care and patient safety.
 The EACPT Scientific Award is for the best scientific paper on a topic relevant to clinical pharmacology and therapeutics published by a European clinical pharmacologist over the period between EACPT congresses, based on nominations by the EACPT Council. Criteria are scientific quality, broader impact in science, and the importance of the work in the context of healthcare delivery.
Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member.
Click here to apply online for EACPT membership.
Membership benefits include:
  • Discounted registration fees for EACPT meetings
  • Access to videos of talks from EACPT Meetings
  • Online access to the Official EACPT Journal - Clinical Therapeutics
  • Access to the EACPT’s worldwide network of Individual Associate Members
  • Active involvement in EACPT 
The EACPT was founded over 20 years ago and now includes all national organisations for clinical pharmacology in Europe. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

EACPT Focus Meeting on How to Assess Medicines: Opatija, Croatia - 6th - 9th October, 2016

The next EACPT Focus Meeting will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics.

The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice".
The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.

The meeting will include a combination of scientific podium lectures, interactive workshops and guided poster sessions covering three main pillars important for the critical assessment of medicinal products - efficacy, effectiveness, and economics (3E assessment).

There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist. 

We will be guests in the Adriatic coastal town Opatija, Croatia. Opatija lies at the centre of the Kvarner Riviera with the longest tradition of providing quality conference venues in Croatia. Opatija’s very attractive geographic location, lush green scenery and a pleasant climate (45° 20’ north latitude) were some of the main reasons for its origins and the rapid development of its tourism from the end of the 19th century.  The venue – Grand Hotel 4 Opatijska Cvijeta –  is located in the very centre of Opatija and includes four buildings that were named after Opatija’s best-known flowers. The hotel has 223 rooms. The hotel also includes the large Tamaris congress centre, which has 7 multi-functional halls and the latest congress equipment. 

Click here to apply online for EACPT membership.

Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
  • Discounted registration fees for EACPT meetings
  • Online access to the Official EACPT Journal - Clinical Therapeutics
  • Access to the EACPT’s worldwide network of Individual Associate Members
  • Active involvement in EACPT 
The EACPT was founded 23 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.
Opatija, Croatia

Update from Barcelona on the EACPT

The EACPT Executive Committee met in Barcelona from 27th - 28th November
Sagrada Familia, Barcelona
to

plan for future activities including its next Focus Meeting to be held in Opatija in Croatia from 6th - 9th October 2016 and the 13th biennial Congress of the EACPT, to be held in Prague, Czech Republic in June 2017. 

The theme of the October 2016 EACPT Focus Meeting is “How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment”. The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner. 

The Prague EACPT Congress in 2017 will provide an international scientific and educational
Members of the EACPT Executive Committee: Sagrada Familia
forum for discussion of clinical pharmacology and personalised pharmacotherapy. Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, innovative techniques, and advanced practices in topics such as drug discovery, drug development, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines. 


There were updates on the progress of current and new working groups for Young Pharmacologists, Ethics, Regulatory issues and Education.

There were also reports on interaction with other professional organisations and societies, including the European Medicines Agency, IUPHAR (the International Union of Pharmacology) and EPHAR (the European Federation of Pharmacology Societies) and an update on interactions with Clinical Therapeutics, the Official Journal of EACPT.

The 2019 EACPT Congress will be held in Stockholm and the 2021 EACPT Congress in Athens. 

Click here to apply online for EACPT membership. 

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
  • Access to videos of talks from EACPT Meetings
  • Discounted registration fees for EACPT meetings
  • Online access to the Official EACPT Journal - Clinical Therapeutics
  • Access to the EACPT’s worldwide network of Individual Associate Members
  • Active involvement in EACPT 
The last EACPT Congress was held in June 2015 in Madrid where over 500 abstracts were presented as e-posters and 54 oral presentations. 

The EACPT was founded 23 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Wednesday 25 November 2015

Join EACPT to access new video library of talks on medicines from 2015 Madrid Congress


The EACPT has just released a library of almost 60 videos of talks from the 2015 Madrid
Plaza Major, Madrid
Congress. These videos are now available for EACPT members within the members’ pages of the EACPT website. See below for the list of speakers and their topics, ranging from Alzheimer's to cancer, treating children, regulating medicines, the patient's voice, medicines for low resource global settings, biosimilars, and patient safety.
Access to the videos is free for Individual Associate members of the EACPT.
To view the videos as an existing EACPT member, open the ‘Publications’ drop down menu on the members' pages of the website.


Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
  • Access to videos of talks from EACPT Meetings
  • Discounted registration fees for EACPT meetings
  • Online access to the Official EACPT Journal - Clinical Therapeutics
  • Access to the EACPT’s worldwide network of Individual Associate Members
  • Active involvement in EACPT 
If you are an existing Individual Associate member of the EACPT and have any query regarding your membership login details for the website, please contact eacptmembership@kenes.com.
This new portfolio of videos enriches the existing library of videos of talks available on the EACPT members’ website from the EACPT Cardiovascular focus meeting held in Nijmegen in 2014.
Main topics and speakers
Biosimilar medicinal products. How to enhance healthcare systems sustainability without compromising clinical practice.
Martina Weise (Germany), Cristina Avendaño-Solá (Spain), Aleksandra Grozdanova (Macedonia)
Debate on therapeutic innovation: Does industry research meet the needs of society?
Xavier Carné (Spain) vs. Ruth Diazaraque (United Kingdom)
Debate on pharmacoepidemiology databases
Miriam CJM Sturkenboom (The Netherlands) vs. Tom MacDonald (United Kingdom)
Current challenges in cancer treatment.
Luis Paz Ares (Spain)
Novel insights in ADME
Janne Backman (Finland), Amin Rostami (United Kingdom)
Handling medicines in special populations
- Renal function in older people: Emmanuelle Vidal-Petiot (France)
- Rational pharmacotherapy in children: Imti Choonara (United Kingdom)
- Appropriate prescribing in older patients: Beatriz Montero (Spain)
Medicines and Global Health
Nicola Magrini (WHO, Switzerland), Lembit Rägo (WHO, Switzerland). Raj Long (Bill and Melinda Gates Foundation, UK), Antoni Plasencia (Spain)
Drug development for regulatory approval and reimbursement decisions
Beate Wieseler (Germany), Pierre Demolis (France), Bruno Flamion (Belgium)
Key factors for successful research in Europe
Rafael de Andrés Medina (Spain), Jacques Demotes (France), Javier Urzay (Spain)
Implementation of Pharmacogenetics and Personalised Medicine in Clinical Practice
Raul A. Kiivet (Estonia)
Interventions that improve the use of medicines in clinical practice
Tormod K Bjånes (Norway), Romaldas Maciulaitis (Lithuania), Milan Grundmann (Czech Republic), Espen Jimenez-Solem (Denmark), Carl-Olav Stiller (Sweden), Mikkel Christensen (Denmark), Cornelis Kramers (Netherlands), Kirstine Moll Harboe (Denmark), Cándido Hernández-López (Spain)
Biomarkers in Alzheimer clinical research
Claudio Babiloni (Italy)
Medicines regulation, access to medicines and the patient’s voice
Denis Pouchain (France), Nick Meade (United Kingdom), Toni Gilabert (Spain)
Heterogeneity in drug response
Juan Tamargo (Spain), Caridad Pontes (Spain), Eduard Vieta (Spain)
Immunopharmacology of TNF-alpha: disease-transcending therapies
Roman Fischer (Germany), Johannan Brandse (The Netherlands), Marie-Christophe Boissier (France)
Pharmacovigilance - Risk communication to health professionals and citizens
Barbara Rath (Germany), Almath Spooner (Ireland), Frederic Bouder (Netherlands)
Drug Information and Decision Support Systems to support rational drug treatment
Robert Vander Stichele (Belgium), Ylva Böttiger (Sweden)
Hepatitis B reactivation. How to manage the risk?
José Luis Calleja (Spain)
Progressive multifocal leukoencephalopathy. Risk perception in the therapeutic context
Brigitte Keller-Stanislawski (Germany)
Registries for long-term risks
Ignacio García Doval (Spain)
Drug Induced Liver Injury
Raúl Andrade (Spain), Paul Watkins (USA), Michael Merz (Switzerland), Herve Le Louët (France)
Training on medicines regulation
Arantxa Sancho, Martina Weise, Jorge Camarero, Antonio Gomez-Oute